{"url":"https://lda.senate.gov/api/v1/filings/ef640e08-5563-462b-8a3d-7ded2d061df4/","filing_uuid":"ef640e08-5563-462b-8a3d-7ded2d061df4","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2013,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/ef640e08-5563-462b-8a3d-7ded2d061df4/print/","filing_document_content_type":"text/html","income":null,"expenses":"159000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Seth Radus, VP, Government Affairs","dt_posted":"2013-07-18T16:20:48.043000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"51 Sawyer Road, Suite 200","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Waltham","registrant_state":"MA","registrant_zip":"02453","registrant":{"id":400647952,"url":"https://lda.senate.gov/api/v1/registrants/400647952/","house_registrant_id":null,"name":"ALERE INC.","description":"Health Management","address_1":"51 Sawyer Road, Suite 200","address_2":null,"address_3":null,"address_4":null,"city":"Waltham","state":"MA","state_display":"Massachusetts","zip":"02453","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELLEN V. CHINIARA","contact_telephone":"+1 781-314-4000","dt_updated":"2022-04-06T16:06:26.252216-04:00"},"client":{"id":193840,"url":"https://lda.senate.gov/api/v1/clients/193840/","client_id":12,"name":"ALERE INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-09-15"},"lobbying_activities":[{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"PEPFAR reauthorization","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54774,"prefix":"mr","prefix_display":"MR.","first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"TRA","general_issue_code_display":"Transportation","description":"Testing for driving under the influence of drugs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54774,"prefix":"mr","prefix_display":"MR.","first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FDA-regulation of in-vitro diagnostic laboratory tets","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54774,"prefix":"mr","prefix_display":"MR.","first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare competitive bidding program","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54774,"prefix":"mr","prefix_display":"MR.","first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Development of new and innovative in-vitro diagnostic tests.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54774,"prefix":"mr","prefix_display":"MR.","first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}